Market closedNon-fractional

HCW Biologics/HCWB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About HCW Biologics

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Ticker

HCWB

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Miramar, United States

Employees

45

HCW Biologics Metrics

BasicAdvanced
$23M
Market cap
-
P/E ratio
-$0.76
EPS
0.94
Beta
-
Dividend rate
$23M
0.94
0.463
0.372
94.667
94.667
-146.89%
-47.07%
-132.46%
5.737
2.68
2.68
-0.79
7.68%
51.15%
-1.43%
-22.50%

What the Analysts think about HCW Biologics

Analyst Ratings

Majority rating from 1 analysts.
Buy

HCW Biologics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-672.72% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1M
-15.38%
Net income
-$7.4M
-30.19%
Profit margin
-672.72%
-17.50%

HCW Biologics Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 114.29%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Actual
-$0.14
-$0.12
-$0.14
-$0.30
Expected
-$0.14
-$0.15
-$0.13
-$0.14
Surprise
0.00%
-18.18%
7.69%
114.29%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for HCW Biologics stock?

HCW Biologics (HCWB) has a market cap of $23M as of July 06, 2024.

What is the P/E ratio for HCW Biologics stock?

The price to earnings (P/E) ratio for HCW Biologics (HCWB) stock is 0 as of July 06, 2024.

Does HCW Biologics stock pay dividends?

No, HCW Biologics (HCWB) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next HCW Biologics dividend payment date?

HCW Biologics (HCWB) stock does not pay dividends to its shareholders.

What is the beta indicator for HCW Biologics?

HCW Biologics (HCWB) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell HCW Biologics stock

Buy or sell HCW Biologics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing